- Egg proteins, including egg white powder, egg yolk powder, and whole egg protein, are increasingly integral to pharmaceutical applications due to their biocompatibility, high protein content, and functional properties that enhance drug formulation and delivery
- The surge in demand is fueled by the growing prevalence of protein-based therapies, increasing focus on dietary supplements for health and wellness, and the expanding use of egg proteins in personalized medicine and nutraceuticals
- North America dominated the egg protein in pharmaceuticals market with the largest revenue share of 31.8% in 2024, driven by advanced pharmaceutical infrastructure, high R&D investments, and a strong presence of key industry players
- Asia-Pacific is expected to be the fastest-growing region during the forecast period, propelled by rising healthcare expenditures, increasing urbanization, and growing demand for functional ingredients in pharmaceuticals, particularly in countries such as China, India, and Japan
- The egg white powder segment dominated the largest market revenue share of 52.3% in 2024, driven by its high protein content, low fat, and versatility in pharmaceutical formulations, particularly for dietary supplements and biologics
